Effectiveness of the Electronic Cigarette: An Eight-Week Flemish Study with Six-Month Follow-up on Smoking Reduction, Craving and Experienced Benefits and Complaints

by Karolien Adriaens, Dinska Van Gucht, Paul Declerck, Frank Baeyens
Published 2014-10-01

Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?

by Roy Fleischmann, Vipul Jairath, Eduardo Mysler, Dave Nicholls, Paul Declerck
Published 2020-01-01

586 Intratumoral DNA-based gene transfer as an efficient delivery approach to combine checkpoint-inhibiting antibodies with interleukin 12

by Kevin Hollevoet, Nick Geukens, Paul Declerck, Liesl Jacobs, Elien De Smidt
Published 2020-11-01

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape

by Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys, Paul Declerck, Arnold G. Vulto, Steven Simoens
Published 2017-06-01

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

by Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys
Published 2021-06-01

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics

by Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, Timothy P. Hickling, Ira A. Jacobs, Jeffrey Chou, Shahram Salek-Ardakani, Eugenia Kraynov
Published 2019-04-01